A coroner has ruled that neglect at a care home contributed to the death of Edith Alden, leading to significant criticisms of the facility's care standards.
Viking Therapeutics' experimental GLP-1 weight loss drug shows promising results, potentially competing with market leaders like Eli Lilly's Zepbound and Mounjaro.